Restricted accessResearch articleFirst published online 2021-01
Antimicrobial Resistance of Serial Isolates of Acinetobacter baumannii Colonizing the Rectum of Adult Intensive Care Unit Patients in a Teaching Hospital in Kuwait
Outbreak and endemic isolates of Acinetobacter baumannii are known to be polyclonal. In an ongoing study, we hypothesized that the patient gut was the source of the polyclonality where genetic exchanges take place. To test the hypothesis, we collected 270 serial rectal isolates from 32 adult intensive care unit patients over 16 months and investigated their drug resistance profiles.
Methods:
Antimicrobial susceptibility was determined according to recommended methods. The blaIMP, blaVIM, blaSIM, blaOXA-23, blaOXA-24/40, blaOXA-51, blaOXA-48,blaKPC,blaGES,blaNDM and blaOXA-58 were sought by PCR. A subset of 42 isolates were studied for plasmid-mediated resistance.
Results:
Most of the 270 isolates were multidrug resistant (MDR; with resistances to meropenem of 85.18% and imipenem of 87.04%), but susceptible to colistin and trimethoprim/sulfamethoxazole. There was no correlation between the pattern of resistance and antibiotics administered to treat infections. There was no consistent pattern of resistance or content of carbapenemase genes in serial rectal isolates suggesting polyclonality of the isolates. Genes mediating production of OXA-23, OXA-24/40, IMP, and GES enzymes were carried on plasmids and they mediated resistance to all carbapenems in conjugation studies.
Conclusion:
A. baumannii colonizing the rectum were polyclonal, MDR, and carbapenem resistance genes were found on plasmids and some plasmids were transferable.
Get full access to this article
View all access options for this article.
References
1.
JamalW., SalamaM., ShahinM., and RotimiV.. 2017. The burden of Acinetobacter baumannii in the intensive care unit of a teaching hospital in Kuwait over a 3-year period. Open Forum Infect. Dis. 4:S174–S175.
2.
JamalW., SalamaM., DehrabN., Al HashemG., ShahinM., and RotimiV.. 2009. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit. J. Hosp. Infect. 72:234–242.
3.
ValenzuelaJ., ThomasL., PartridgeS., van der ReijdenT., DijkshoornL., and IredellJ.. 2007. Horizontal gene transfer in a polyclonal outbreak of carbapenem-resistant Acinetobacter baumannii. J. Clin. Microbiol. 45:453–460.
4.
DijkshoornL., Van VianenW., DegenerJ., and MichelM.. 1987. Typing of Acinetobacter calcoaceticus strains isolated from hospital patients by cell envelope protein profiles. Epidemiol. Infect. 99:659–667.
5.
HigginsP., WisplinghoffH., KrutO., and SeifertH.. 2007. A PCR-based method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TU. Clin. Microbiol. Infect. 13:1200–1201.
6.
Clinical and Laboratory Standards Institute (CLSI). 2018. Performance Standards for Antimicrobial Susceptibility Testing, 28th ed. CLSI Supplement M100 (ISBN 1-56238-838-X [Print]; ISBN 1-56238-839-8 [Electronic]). Clinical and Laboratory Standards Institute, Wayne, PA.
7.
TalagaK., KrzyściakP., and BulandaM.. 2016. Susceptibility to tigecycline of Acinetobacter baumannii strains isolated from intensive care unit patients. Anestezjol. Intens. Ter. 48:166–170.
8.
MostachioA.K., Van Der HeidjenI., RossiF., LevinA., CostaS.. 2009. Multiplex PCR for rapid detection of genes encoding oxacillinases and metallo-β-lactamases in carbapenem-resistant Acinetobacter spp. J. Med. Microbiol. 58:1522–1524.
9.
SrinivasanR., EllappanK., and NarasimhaH.. 2015. Prevalence and characterization of NDM-1 and OXA-48 carbapenemase gene harboring Enterobacteriaceae in a tertiary care hospital, South India. African Bacteriol. Res. 7:60–63.
10.
PoirelL., WalshT., CuvillierV., and NordmannP.. 2011. Multiplex PCR for detection of acquired carbapenemase genes. Diagn. Microbiol. Infect. Dis. 70:119–123.
11.
HongS., KimK., HuhJ.Y, JungB., KangM., and HongS.. 2012. Multiplex PCR for rapid detection of genes encoding class A carbapenemases. Ann. Lab. Med. 32:359–361.
12.
RoutrayA., LavanyaP., SoniyaR., and MadhavanR.. 2013. Multiplex PCR for genes encoding prevalent OXA and NDM-1 carbapenemases in Acinetobacter. J. Pharm. Res. 7:324–326.
13.
BertiniA., PoirelL., MugnierP., VillaL., NordmannP., and CarattoliA.. 2010. Characterization and PCR-based replicon typing of resistance plasmids in Acinetobacter baumannii. Antimicrob. Agents Chemother. 54:4168–4177.
14.
KadoC., and LiuS.. 1981. Rapid procedure for detection and isolation of large and small plasmids. J. Bacteriol. 145:1365–1373.
15.
LiuY., WangY., WalshT., YiL., ZhangR., SpencerJ., DoiY., TianG., DongB., HuangX., and YuL.. 2016. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect. Dis. 16:161–168.
AljindanR., BukharieH., AlomarA., and AbdalhamidB.. 2015. Prevalence of digestive tract colonization of carbapenem-resistant Acinetobacter baumannii in hospitals in Saudi Arabia. J. Med. Microbiol. 64: 400–406.
18.
AyobamiO., WillrichN., HarderT., OkekeI., EckmannsT., and MarkwartR.. 2019. The incidence and prevalence of hospital-acquired (carbapenem-resistant) Acinetobacter baumannii in Europe, Eastern Mediterranean and Africa: a systematic review and meta-analysis. Emerg. Microbes Infect. 8:1747–1759.
19.
KarampatakisT., AntachopoulosC., TsakrisA., and RoilidesE.. 2017. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in Greece: an extended review (2000–2015). Future Microbiol. 12: 801–815.
20.
RobenshtokE., PaulM., LeiboviciL., FraserA., PitlikS., OstfeldI., SamraZ., PerezS., LevB., and WeinbergerM.. 2006. The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomes. J. Hosp. Infect. 64:282–287.
21.
Martínez-PellúsA., GómezJ., SánchezF., CórdobaE., and LozanoJ.. 2002. Incidence of colonization and infection due to Acinetobacter baumannii in an ICU with a situation of endemic. Analysis of risk factors through a study of vigilance. [translated from Spanish] Enferm. Infec. Microbiol. Clin. 20:194–199.
22.
PerezF., HujerA., HujerK., DeckerB., RatherP., and BonomoR.. 2007. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 51:3471–3484.
23.
Al MobarakM., MatbuliR., and MeirH.. 2014. Antimicrobial resistance patterns among Acinetobacter baumannii isolated from King Abdulaziz hospital—Jeddah—Saudi Arabia: four year surveillance study (2010–2013). Egypt J. Med. Microbiol. 23:53–60.
24.
Gündeşlioğlu, Ö., GökmenT., Ö. Horoz, AksarayN., KöksalF., YamanA., YıldızdaşR., AlhanE., KocabaşE., and AlabazD.. 2014. Molecular epidemiology and antibiotic susceptibility pattern of Acinetobacter baumannii isolated from children in a Turkish university hospital. Turk. J. Pediatr. 56:360–367.
25.
Al-SweihN., Al-HubailM., and RotimiV.. 2012. Three distinct clones of carbapenem-resistant Acinetobacter baumannii with high diversity of carbapenemases isolated from patients in two hospitals in Kuwait. J. Infect. Public Health. 5:102–108.
26.
Al-SweihN., Al-HubailM., and RotimiV.. 2011. Emergence of tigecycline and colistin resistance in Acinetobacter species isolated from patients in Kuwait hospitals. J. Chemother. 23:13–16.
27.
GanjoA., MaghdidD., MansoorI., KokD., SeverinJ., VerbrughH., KreftD., FatahM., AlnakshabandiA., DlnyaA., and HammerumA.. 2016. OXA-carbapenemases present in clinical Acinetobacter baumannii-calcoaceticus complex isolates from patients in Kurdistan region, Iraq. Microb. Drug Resist. 22:627–637.
28.
ZowawiH., SartorA., SidjabatH., BalkhyH., WalshT., Al JohaniS., AlJindanR., AlfaresiM., IbrahimE., Al-JardaniA., and Al SalmanJ.. 2015. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates in the Gulf Cooperation Council States: dominance of OXA-23-type producers. J. Clin. Microbiol. 53:896–903.
29.
RezaeiA., FazeliH., MoghadampourM., HalajiM., and FaghriJ.. 2018. Determination of antibiotic resistance pattern and prevalence of OXA-type carbapenemases among Acinetobacter baumannii clinical isolates from inpatients in Isfahan, central Iran. Infez. Med. 26:61–66.
30.
BonninR., RotimiV., Al HubailM., GasiorowskiE., Al SweihN., NordmannP., and PoirelL.. 2013. Wide dissemination of GES-type carbapenemases in Acinetobacter baumannii isolates in Kuwait. Antimicrob. Agents Chemother. 57:183–188.
31.
Al-AgamyM., JeannotK., El-MahdyT., ShiblA., KattanW., PlésiatP., and CourvalinP.. 2017. First detection of GES-5 carbapenemase-producing Acinetobacter baumannii isolate. Microb. Drug Resist. 23:556–562.
32.
ChuY., Afzal-ShahM., HouangE., PalepouM., LyonD., WoodfordN., and LivermoreD.M. 2001. IMP-4, a novel metallo-β-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998. Antimicrob. Agents Chemother. 45:710–714.
33.
LeeK., LeeW., UhY., HaG., ChoJ., and ChongY.. 2003. Korean nationwide surveillance of antimicrobial resistance group. VIM-and IMP-type metallo-β-lactamase–producing Pseudomonas spp. and Acinetobacter spp. in Korean hospitals. Emerg. Infect. Dis. 9:868–871.
34.
EvansB.A., and AmyesS.. OXA β-lactamases. 2014. Clin. Microbiol. Rev. 27:241–263.
35.
SantimaleeworagunW., SamretW., PreechachuawongP., KerdsinA., and JitwasinkulT.. 2016. Emergence of co-carbapenemase genes, blaOXA23, blaVIM, and blaNDM in carbapenem resistant Acinetobacter baumannii clinical isolates. Southeast Asian J. Trop. Med. Public Health, 47:1001–1007.
36.
SaranathanR., SudhakarR., SinghS., ShashikalaP., KanungoR., and PrashanthK.. 2014. Multiple drug resistant carbapenemases producing Acinetobacter baumannii isolates harbours multiple R-plasmids. Indian J. Med. Res. 140:262–270.
37.
LeeK., YumJ., YongD., LeeH., KimH., DocquierJ., RossoliniG., and ChongY.. 2005. Novel acquired metallo-β-lactamase gene, blaSIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob. Agents Chemother. 49:4485–4491.
38.
MendesR.E., KiyotaK.A, MonteiroJ., CastanheiraM., AndradeS.S, GalesA.C, PignatariA., and TufikS.. 2007. Rapid detection and identification of metallo-β-lactamase-encoding genes by multiplex real-time PCR assay and melt curve analysis. J. Clin. Microbiol. 45:544–547.
39.
HamidianM., and HallR.. 2018. Genetic structure of four plasmids found in Acinetobacter baumannii isolate D36 belonging to lineage 2 of global clone 1, PLoS One, 13:e0204357.
40.
WangS., ZhouK., XiaoS., XieL., GuF., LiX., NiY., SunJ., and HanL.. 2019. A multidrug resistance plasmid pIMP26, carrying blaIMP-26, fosA5, blaDHA-1, and qnrB4 in Enterobacter cloacae. Sci. Rep. 9:10212.
41.
HameedF., KhanM., MuhammadH., SarwarT., BilalH., and RehmanT.. 2019. Plasmid-mediated MCR-1 gene in Acinetobacter baumannii. and Pseudomonas aeruginosa: first report from Pakistan. Rev. Soc. Bras. Med. Trop. 52: e2019, 0237.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
